Myers, Andrea P <br/><br/>
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.  [electronic resource] 

 -  International journal of cancer  07 2020 
 - 413-422 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.32783  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Class I Phosphatidylinositol 3-Kinases--genetics<br/>Drug Administration Schedule<br/>Endometrial Neoplasms--drug therapy<br/>Female<br/>Heterocyclic Compounds, 3-Ring--administration & dosage<br/>Humans<br/>Middle Aged<br/>Mutation<br/>Neoplasm Recurrence, Local--drug therapy<br/>Precision Medicine<br/>Treatment Outcome